Yang Y - Search Results

1

Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates.

Yang Y, Zhou Z, He S, Fan T, Jin Y, Zhu X, Chen C, Zhang ZR, Huang Y. Yang Y, et al. Biomaterials. 2012 Mar;33(7):2260-71. doi: 10.1016/j.biomaterials.2011.12.007. Epub 2011 Dec 19. Biomaterials. 2012. PMID: 22189143

2

Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles.

Zhou Z, Li L, Yang Y, Xu X, Huang Y. Zhou Z, et al. Among authors: yang y. Biomaterials. 2014 Aug;35(24):6622-35. doi: 10.1016/j.biomaterials.2014.04.059. Epub 2014 May 10. Biomaterials. 2014. PMID: 24814427

3

Comparison of active and passive targeting of doxorubicin for somatostatin receptor 2 positive tumor models by octreotide-modified HPMA copolymer-doxorubicin conjugates.

He S, Zhou Z, Li L, Yang Q, Yang Y, Guan S, Zhang J, Zhu X, Jin Y, Huang Y. He S, et al. Among authors: yang q, yang y. Drug Deliv. 2016;23(1):285-96. doi: 10.3109/10717544.2014.911991. Epub 2014 May 28. Drug Deliv. 2016. PMID: 24865288 Free article.

4

Targeting prostate carcinoma by G3-C12 peptide conjugated N-(2-hydroxypropyl)methacrylamide copolymers.

Yang Y, Li L, Zhou Z, Yang Q, Liu C, Huang Y. Yang Y, et al. Among authors: yang q. Mol Pharm. 2014 Oct 6;11(10):3251-60. doi: 10.1021/mp500083u. Epub 2014 Jun 30. Mol Pharm. 2014. PMID: 24955652

5

Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer.

Yang Q, Yang Y, Li L, Sun W, Zhu X, Huang Y. Yang Q, et al. Among authors: yang y. ACS Appl Mater Interfaces. 2015 Apr 1;7(12):6661-73. doi: 10.1021/am509204u. Epub 2015 Mar 23. ACS Appl Mater Interfaces. 2015. PMID: 25775367

6

Synthesis and in vitro anti-tumor activity of novel HPMA copolymer-drug conjugates with potential cell surface targeting property for carcinoma cells.

Xiang Q, Yang Y, Zhou Z, Zhou D, Jin Y, Zhang Z, Huang Y. Xiang Q, et al. Among authors: yang y. Eur J Pharm Biopharm. 2012 Feb;80(2):379-86. doi: 10.1016/j.ejpb.2011.10.020. Epub 2011 Nov 12. Eur J Pharm Biopharm. 2012. PMID: 22101181

7

Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.

Fan T, Chen C, Guo H, Xu J, Zhang J, Zhu X, Yang Y, Zhou Z, Li L, Huang Y. Fan T, et al. Among authors: yang y. Eur J Pharm Biopharm. 2014 Oct;88(2):518-28. doi: 10.1016/j.ejpb.2014.06.011. Epub 2014 Jun 24. Eur J Pharm Biopharm. 2014. PMID: 24968819

8

An in vitro investigation of a detachable fork-like structure as efficient nuclear-targeted sub-unit in A2780 cell cultures.

Guan S, Li L, Zhu X, Yang Y, Zhang Z, Huang Y. Guan S, et al. Among authors: yang y. Int J Pharm. 2016 Mar 16;500(1-2):100-9. doi: 10.1016/j.ijpharm.2016.01.033. Epub 2016 Jan 16. Int J Pharm. 2016. PMID: 26784985

9

Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids.

Chen C, Fan T, Jin Y, Zhou Z, Yang Y, Zhu X, Zhang ZR, Zhang Q, Huang Y. Chen C, et al. Among authors: yang y. Nanomedicine (Lond). 2013 Jul;8(7):1085-100. doi: 10.2217/nnm.12.141. Epub 2012 Oct 17. Nanomedicine (Lond). 2013. PMID: 23075315

10

A novel strategy for encapsulating poorly soluble drug into nanostructured lipid carriers for intravenous administration.

Zhao C, Liu Y, Fan T, Zhou D, Yang Y, Jin Y, Zhang Z, Huang Y. Zhao C, et al. Among authors: yang y. Pharm Dev Technol. 2012 Jul-Aug;17(4):443-56. doi: 10.3109/10837450.2010.546411. Epub 2011 Jan 11. Pharm Dev Technol. 2012. PMID: 21222507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110,562 results

Search Page

Filters